13 – 16 NOVEMBER 2023


Since 1991, the AGITG has been the only research organisation in the Australasian region with a focus on all gastro-intestinal cancers. This year we invite you to join us in Aotearoa New Zealand for our 25th AGITG Annual Scientific Meeting where we will focus on equity, diversity, and inclusion in clinical trials. The theme stems from the pressing need to extend access and increase equity to therapeutic options across regional, rural, and remote (RRR) areas, as well as culturally diverse and First Nations population.

The ASM is a major highlight of the year, providing an opportunity for increased involvement in the scientific activities of the AGITG and encouraging subsequent ongoing participation in the group’s research. This year’s ASM will be no different and will encourage collaboration between members across Australia and New Zealand.

Our conference will provide an innovative platform to engage members with new research concept, trial developments, diverse panel discussions and Q&A sessions. We look forward to hearing from international and local renowned invited speakers and acknowledge outstanding achievements from members with the presentation of awards and the Innovation Grant.

We look forward to you joining us in Christchurch!

Dr Ben Lawrence and Professor Stephen Ackland
AGITG Annual Scientific Meeting Co-Convenors

Dr Ben Lawrence
Professor Stephen Ackland


Our Speakers

In Person Speakers AGITG 2023
International Speaker, Prof Laura Dawson, University of Toronto, Toronto, USA
Dr. Diane Simeone, Laura and Isaac Perlmutter Professor of Surgery and Pathology at New York University, USA
International Speaker, Prof Leonard Saltz, Memorial Sloan-Kettering Cancer Center, New York, USA
International Speaker, A/Prof Katherine Garman, Duke University in Durham, North Carolina, USA

Save 10% on Flights

As a delegate, you can also access a 10% discount on all flights with Air New Zealand. The deadline is 30 September 2023, so make sure you book your tickets soon. Use promo code ‘AGI23’.
*Over a specific booking period of 17 weeks, 1 May to 1 September 2023 delegates will be able to access fares with a discount of up to 10%. The proposed travel period will be 05 to 23 November 2023, giving a week either side of the conference for delegates to extend their stay if they wish. This will be for return travel ex Australia and through to Christchurch.

For more information


Visit: asm.gicancer.org.au 

Call: 1300 666 769

Email: agitg@gicancer.org.au

Featured Posts

AGITG 2023 Wrap-Up with Katie Garman and Ben Lawrence
Episode 26 AGITG 2023 Wrap-Up with Katie Garman and Ben Lawrence How can we change our inner worlds alongside our healthcare systems? How can we integrate trust and kindness into research projects? How...
Read More
AGITG 25th Annual Scientific Meeting: Navigating a Path to Equity in GI Cancer Research
Q&A with Meeting Co-Convenor Dr Ben Lawrence, Head of Oncology at University of Auckland & Medical Oncologist at Te Puriri o Te Ora Auckland Hospital, Aotearoa New Zealand. We sat down with Dr....
Read More
GI Update with Eugene Koay and Lizzy Smyth
AGITG ASM Special Episode of Experts on Point Will AI replace radiation oncologists? What are the best treatment options for patients with operable gastroesophageal adenocarcinoma? Our Host Rachael Bab...
Read More
ASCO GI: International clinical trial demonstrates improved survival with new treatment for patients with advanced gastro-oesophageal cancer
The AGITG and NHMRC CTC today announced that the INTEGRATE IIa study, a phase III trial evaluated regorafenib for the treatment of patients with advanced gastro-oesophageal cancer (AGOC), has met its primary...
Read More
Celebrating 30 Years at the AGITG Annual Scientific Meeting
The Australasian Gastro Intestinal Trails Group (AGITG), held their 23rd Annual Scientific Meeting on 12-15 October. Held virtually for the second year.  Over 545 delegates, a record number of attendees...
Read More
Applying artificial intelligence in treating Gastro-Intestinal Cancer is now a reality thanks to a grant awarded by the AGITG
Professor Niall Tebbutt has been awarded the Gastric Cancer Research Grant (including Linitis Plastica) to develop and apply artificial intelligence (AI) based image analysis for scoring PD-L1 immunohistochemistry...
Read More
Latrobe Regional Hospital’s Clinical Trials Coordinator receives an Award for Excellence in Study Coordination
Latrobe Regional Hospital Clinical Trials Coordinator, Ms Joanne Parr was recently honoured for her outstanding work in coordinating innovative and ground-breaking treatments for gastro-intestinal cancer...
Read More
Professor Mark Smithers receives John Zalcberg OAM Award for his dedication to gastro-intestinal cancer research
Surgical oncologist Professor Mark Smithers AM was honoured for his 30-year commitment to discovering better treatments for gastro-intestinal cancers at the 23rd Australasian Gastro-Intestinal Trials Group...
Read More
Professor Nick Pavlakis - Leader of Treks and Trials
Inspired by the efforts of his colleagues, medical oncologist Professor Nick Pavlakis decided it was his turn to give back to the GI Cancer Institute and help his patients in another way. A decision that...
Read More
Celebrating 30 years at the AGITG ASM
As the Australasian Gastro-Intestinal Trials Group (AGITG) celebrate their 30th anniversary, join them for their Annual Scientific Meeting (ASM) and be a part of the event that is changing the odds for...
Read More